Acura Pharmaceuticals (OTCMKTS:ACUR) Shares Cross Above Two Hundred Day Moving Average – Time to Sell?

Shares of Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.0001. Acura Pharmaceuticals shares last traded at $0.0001, with a volume of 6,600 shares traded.

Acura Pharmaceuticals Stock Down 100.0%

Acura Pharmaceuticals Company Profile

Acura Pharmaceuticals Inc is a specialty pharmaceutical company focused on developing and commercializing products designed to deter prescription drug abuse and misuse. The company’s core business centers on proprietary drug formulations that incorporate its Aversion and ARCUS® abuse-deterrent technologies. These platforms are intended to make it more difficult to tamper with or extract active pharmaceutical ingredients from oral dosage forms, helping to address public health concerns around opioid and stimulant abuse.

Acura’s lead product, Oxaydo®, is an immediate?release oxycodone tablet that employs Aversion® technology to discourage tampering and intravenous abuse.